We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Autonomix, we're developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. This opens us up to a world of possibilities in the field of electrophysiology. Clinical trials start this year for the treatment of pan... Autonomix, we're developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. This opens us up to a world of possibilities in the field of electrophysiology. Clinical trials start this year for the treatment of pancreatic cancer pain and pancreatitis pain. Show more
THE WOODLANDS, TX, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (βAutonomixβ or the βCompanyβ), a medical device company focused on advancing innovative technologies...
Continued efforts to build team and infrastructure required to support clinical and regulatory initiatives in anticipation of the FDA approval process for first-in-class catheter-based sensing...
First-in-class catheter-based sensing technology designed to sense neuronal signals that indicate pain or disease and destroy those nerves at the source Company expects to submit an...
THE WOODLANDS, TX, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (βAutonomixβ or the βCompanyβ), a medical device company focused on advancing precision nerve-targeted...
THE WOODLANDS, TX, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (βAutonomixβ or the βCompanyβ), a medical device company focused on advancing precision nerve-targeted...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.35 | 11.1111111111 | 3.15 | 3.6 | 2.88 | 148769 | 3.32226717 | CS |
4 | -3.15 | -47.3684210526 | 6.65 | 6.65 | 2.88 | 149624 | 4.13171145 | CS |
12 | -8.7 | -71.3114754098 | 12.2 | 21.49 | 2.88 | 652122 | 11.62060931 | CS |
26 | -17.1 | -83.0097087379 | 20.6 | 42.4 | 2.88 | 2675819 | 23.66786916 | CS |
52 | -148.5 | -97.6973684211 | 152 | 152 | 2.88 | 1531898 | 24.4676245 | CS |
156 | -148.5 | -97.6973684211 | 152 | 152 | 2.88 | 1531898 | 24.4676245 | CS |
260 | -148.5 | -97.6973684211 | 152 | 152 | 2.88 | 1531898 | 24.4676245 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions